{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:18:58Z","timestamp":1778692738508,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jieyun Yin","award":["82273635"],"award-info":[{"award-number":["82273635"]}]},{"name":"Qiuping Ma","award":["TC2021JCYL03"],"award-info":[{"award-number":["TC2021JCYL03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Several randomized clinical trials showed that aspirin could decrease the incidence of preeclampsia (PE) in women at high risk, but data from sources other than traditional clinical trials that investigating the preventive effect of aspirin 75\u00a0mg on PE is still lacking, especially in mainland China. We aimed to use Chinese real-world data to estimate the preventive effect of low-dose aspirin (LDA) on PE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical data of pregnant women who were at high risk of PE and had their first prenatal visit at the affiliated Taicang People\u2019s Hospital of Soochow University during November 31, 2018 and May 10, 2021 was retrospectively analyzed. Among the 266 included pregnant women, 115 individuals treated with aspirin 75\u00a0mg per day and the other 151 without such treatment were considered as the LDA group and the control group, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the LDA group, 64 (55.65%) of 115 pregnant women took aspirin before 16\u00a0weeks of gestation. Besides, 12 (10.43%) and 34 (22.52%) women developed PE in the LDA group and control group, respectively; the aspirin prophylaxis was associated with a lower risk of PE (odds ratio\u2009=\u20090.40, 95% confidence interval\u2009=\u20090.20\u20130.82,<jats:italic>P<\/jats:italic>\u2009=\u20090.0098). In addition, LDA is slightly more effective when initiated before 16\u00a0weeks of gestation or in those without chronic hypertension, when compared with their counterparts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prophylaxis with 75\u00a0mg per day of aspirin in high-risk women resulted in a significantly lower incidence of PE than that in the control group.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40001-023-01024-7","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T05:08:10Z","timestamp":1675314490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aspirin 75\u00a0mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China"],"prefix":"10.1186","volume":"28","author":[{"given":"Yue","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"issue":"10297","key":"1024_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341\u201354.","journal-title":"Lancet"},{"issue":"6","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237\u201360.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. Hypertensive disorders of pregnancy: isshp classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension"},{"issue":"10022","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999\u20131011.","journal-title":"Lancet"},{"issue":"18","key":"1024_CR5","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jacc.2014.02.529","volume":"63","author":"R Ahmed","year":"2014","unstructured":"Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014;63(18):1815\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1024_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.116.08414","volume":"69","author":"IV Alsnes","year":"2017","unstructured":"Alsnes IV, Vatten LJ, Fraser A, Bj\u00f8rngaard JH, Rich-Edwards J, Romundstad PR, \u00c5svold BO. Hypertension in pregnancy and offspring cardiovascular risk in young adulthood: prospective and sibling studies in the HUNT Study (Nord-Tr\u00f8ndelag Health Study) in Norway. Hypertension. 2017;69(4):591\u20138.","journal-title":"Hypertension"},{"key":"1024_CR7","first-page":"12381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:12381.","journal-title":"BMJ"},{"issue":"4","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/uog.18816","volume":"50","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LCY, Syngelaki A, O\u2019Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10220","key":"1024_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","volume":"395","author":"MK Hoffman","year":"2020","unstructured":"Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bose CL, Mwapule A, Mwenechanya M, Chomba E, Carlo WA, Chicuy J, Figueroa L, Garces A, Krebs NF, Jessani S, Zehra F, Saleem S, Goldenberg RL, Kurhe K, Das P, Patel A, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Goco N, Hemingway-Foday J, Moore J, Nolen TL, McClure EM, Koso-Thomas M, Miodovnik M, Silver R, Derman RJ. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285\u201393.","journal-title":"Lancet"},{"issue":"3","key":"1024_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10641955.2016.1178772","volume":"35","author":"J Gan","year":"2016","unstructured":"Gan J, He H, Qi H. Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians: a systematic review and meta-analysis. Hypertens Pregnancy. 2016;35(3):426\u201335.","journal-title":"Hypertens Pregnancy"},{"issue":"3","key":"1024_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000336662","volume":"31","author":"S Roberge","year":"2012","unstructured":"Roberge S, Villa P, Nicolaides K, Gigu\u00e8re Y, Vainio M, Bakthi A, Ebrashy A, Bujold E. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141\u20136.","journal-title":"Fetal Diagn Ther"},{"key":"1024_CR12","unstructured":"WHO Recommendations for prevention and treatment of pre-eclampsia and eclampsia. World Health Organization. Published 2011. https:\/\/www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/9789241548335\/en\/ Accessed from 2 Aug 2021."},{"issue":"1","key":"1024_CR13","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"1024_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","volume":"161","author":"ML LeFevre","year":"2014","unstructured":"LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: us preventive services task force recommendation statement. Ann Intern Med. 2014;161(11):819\u201326.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1024_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Stevermer J, Tseng CW, Wong JB. Aspirin use to prevent preeclampsia and related morbidity and mortality: us preventive services task force recommendation statement. JAMA. 2021;326(12):1186\u201391.","journal-title":"JAMA"},{"key":"1024_CR16","unstructured":"Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association (2020). Zhonghua fu chan ke za zhi, 55(4), 227\u201338."},{"key":"1024_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5119","volume":"366","author":"K Webster","year":"2019","unstructured":"Webster K, Fishburn S, Maresh M, Findlay SC, Chappell LC. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366: l5119.","journal-title":"BMJ"},{"issue":"7","key":"1024_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S1701-2163(16)32887-0","volume":"30","author":"MJ Martel","year":"2008","unstructured":"Martel MJ. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(7):562.","journal-title":"J Obstet Gynaecol Can"},{"key":"1024_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.06.021","volume":"193","author":"C Vayssi\u00e8re","year":"2015","unstructured":"Vayssi\u00e8re C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, Gascoin G, Gaudineau A, Grang\u00e9 G, Houfflin-Debarge V, Langer B, Malan V, Marcorelles P, Nizard J, Perrotin F, Salomon L, Senat MV, Serry A, Tessier V, Truffert P, Tsatsaris V, Arnaud C, Carbonne B. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the french college of gynaecologists and obstetricians. Eur J Obstet Gynecol Reprod Biol. 2015;193:10\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"1024_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199803123381101","volume":"338","author":"S Caritis","year":"1998","unstructured":"Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk national institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1998;338(11):701\u20135.","journal-title":"N Engl J Med"},{"issue":"4","key":"1024_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","volume":"168","author":"JC Hauth","year":"1993","unstructured":"Hauth JC, Goldenberg RL, Parker CR Jr, Philips JB 3rd, Copper RL, DuBard MB, Cutter GR. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol. 1993;168(4):1083\u201391.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1024_CR22","first-page":"826","volume":"46","author":"A Ebrashy","year":"2005","unstructured":"Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery doppler ultrasound at 14\u201316 weeks pregnancy: randomized controlled clinical trial. Croat Med J. 2005;46(5):826\u201331.","journal-title":"Croat Med J"},{"key":"1024_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejogrb.2020.03.038","volume":"248","author":"W Gu","year":"2020","unstructured":"Gu W, Lin J, Hou YY, Lin N, Song MF, Zeng WJ, Shang J, Huang HF. Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: a randomized controlled trial from Shanghai, China. Eur J Obstet Gynecol Reprod Biol. 2020;248:156\u201363.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1024_CR24","first-page":"355","volume":"32","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xiao LP, Hu H, Yang XN. Low-dose aspirin prescribed at bed time for the prevention of pre-eclampsia in high-risk pregnant women. Contracept Reprod. 2012;32:355\u20139.","journal-title":"Contracept Reprod"},{"key":"1024_CR25","first-page":"98","volume":"15","author":"E Mesdaghinia","year":"2011","unstructured":"Mesdaghinia E, Talari H, Abedzadeh-Kalahroudi M. Effect of aspirin for prevention of preeclampsia in women with abnormal ultrasonic findings in uterine artery. Feyz J Kashan Univ Med Sci. 2011;15:98\u2013104.","journal-title":"Feyz J Kashan Univ Med Sci"},{"issue":"1\u20132","key":"1024_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/07420528.2012.717455","volume":"30","author":"DE Ayala","year":"2013","unstructured":"Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30(1\u20132):260\u201379.","journal-title":"Chronobiol Int"},{"issue":"10","key":"1024_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/hr.2011.111","volume":"34","author":"A Bakhti","year":"2011","unstructured":"Bakhti A, Vaiman D. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res. 2011;34(10):1116\u201320.","journal-title":"Hypertens Res"},{"issue":"7","key":"1024_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613\u201322.","journal-title":"N Engl J Med"},{"issue":"17","key":"1024_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","volume":"329","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women the national institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1993;329(17):1213\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"1024_CR30","first-page":"293","volume":"105","author":"J Golding","year":"1998","unstructured":"Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. J Obstet Gynaecol. 1998;105(3):293\u20139.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"1024_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","volume":"105","author":"YE Rotchell","year":"1998","unstructured":"Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, Ayers S, Hennis A, Grant A, Duley L, Collins R. Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 1998;105(3):286\u201392.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"1024_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/uog.14889","volume":"46","author":"AO Odibo","year":"2015","unstructured":"Odibo AO, Goetzinger KR, Odibo L, Tuuli MG. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2015;46(4):414\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"1024_CR33","first-page":"265","volume":"10","author":"A Jamal","year":"2012","unstructured":"Jamal A, Milani F, Al-Yasin A. Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med. 2012;10(3):265\u201370.","journal-title":"Iran J Reprod Med"},{"issue":"5","key":"1024_CR34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","volume":"110","author":"D Subtil","year":"2003","unstructured":"Subtil D, Goeusse P, Puech F, Lequien P, Biausque S, Breart G, Uzan S, Marquis P, Parmentier D, Churlet A. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 1). BJOG. 2003;110(5):475\u201384.","journal-title":"BJOG"},{"issue":"1","key":"1024_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","volume":"120","author":"PM Villa","year":"2013","unstructured":"Villa PM, Kajantie E, R\u00e4ikk\u00f6nen K, Pesonen AK, H\u00e4m\u00e4l\u00e4inen E, Vainio M, Taipale P, Laivuori H. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG. 2013;120(1):64\u201374.","journal-title":"BJOG"},{"key":"1024_CR36","first-page":"251","volume":"226","author":"L Lin","year":"2021","unstructured":"Lin L, Huai J, Li B, Zhu Y, Juan J, Zhang M, Cui S, Zhao X, Ma Y, Zhao Y, Mi Y, Ding H, Chen D, Zhang W, Qi H, Li X, Li G, Chen J, Zhang H, Yu M, Sun X, Yang H. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2021;226:251.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1024_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/uog.218","volume":"22","author":"CK Yu","year":"2003","unstructured":"Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2003;22(3):233\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"1024_CR38","first-page":"1","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","unstructured":"ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133(1):1.","journal-title":"Obstet Gynecol"},{"issue":"23","key":"1024_CR39","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2013.6235","volume":"309","author":"CY Spong","year":"2013","unstructured":"Spong CY. Defining \u201cterm\u201d pregnancy: recommendations from the Defining \u201cTerm\u201d Pregnancy Workgroup. JAMA. 2013;309(23):2445\u20136.","journal-title":"JAMA"},{"issue":"2","key":"1024_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","volume":"70","author":"SW Walsh","year":"2004","unstructured":"Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2004;70(2):223\u201332.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6 Pt 2","key":"1024_CR41","first-page":"V19","volume":"62","author":"JB Smith","year":"1980","unstructured":"Smith JB, Araki H, Lefer AM. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation. 1980;62(6 Pt 2):V19-25.","journal-title":"Circulation"},{"issue":"2s","key":"1024_CR42","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2s):S1108-s1119.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1024_CR43","first-page":"551","volume":"74","author":"BM Sibai","year":"1989","unstructured":"Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol. 1989;74(4):551\u20137.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1024_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","volume":"216","author":"S Roberge","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110-120.e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"1024_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Gigu\u00e8re Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402\u201314.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1024_CR46","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ajog.2020.07.020","volume":"226","author":"P Chaemsaithong","year":"2022","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2):1071\u201310972.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1024_CR47","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","volume":"217","author":"LC Poon","year":"2017","unstructured":"Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):585.e1-585.e5.","journal-title":"Am J Obstet Gynecol"},{"key":"1024_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134\u2013135","author":"AC Staff","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019;134\u2013135:1\u201310.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"1024_CR49","doi-asserted-by":"publisher","first-page":"419.e1","DOI":"10.1016\/j.ajog.2020.03.004","volume":"223","author":"C Banala","year":"2020","unstructured":"Banala C, Moreno S, Cruz Y, Boelig RC, Saccone G, Berghella V, Schoen CN, Roman A. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2020;223(3):419.e1-419.e16.","journal-title":"Am J Obstet Gynecol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01024-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T01:46:39Z","timestamp":1701827199000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01024-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01024-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the affiliated Taicang People\u2019s Hospital of Soochow University, Suzhou\u00a0(2020-XJS-130).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}